ZURICH, April 14 (Reuters) - Swiss generic drug manufacturer Sandoz (SDZ.S), opens new tab said on Monday it had filed an antitrust lawsuit in the United States against Amgen (AMGN.O), opens new ...

Sandoz has filed an antitrust lawsuit in the United States against Amgen, for extending and entrenching the dominant market position of its blockbuster medicine, Enbrel (etanercept). The drug was ...

Sandoz has filed an antitrust lawsuit in the US against Amgen, challenging alleged anti-competitive practices surrounding the biologic blockbuster Enbrel (etanercept). Filed at the US District ...

Submitted on Friday, Sandoz's lawsuit alleged Amgen has used a "thicket of patents" to protect its monopoly for Enbrel through 2029 in violation of U.S. federal antitrust law. Filed in a Norfolk ...

ZURICH (Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United States against Amgen over the alleged entrenchment of the market position of ...